I am amazed by the productivity of this little company!
"Having established clinical activity of our anti-PD-1 and anti-CTLA-4 programs, our scientists are sprinting to discover curative combinations. Agenus’ discovery platforms have delivered 5 INDs in 2016-17 and 4 more so far this year for a total of 9 INDs. We are on track to file 2 additional INDs by year end and 2 more in 1H 2019. This would make a total of 13 INDs in ~3 years, an I-O industry record."
With several partnerships just around the corner...we should see some share price movement. It was only the financial questions which have been holding this back. It should be a double digit share price IMO!